Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00714220 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 107
Last updated 2015-10-29
Summary
The work of Nau et. al (Nau KL, Bromberg MB, Forshew DA, Katcha Vl. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995;129 :47-49) showed that patients in the early stages of ALS initially increase their body fat. Another study showed that advanced ALS patients on mechanical ventilation were actually hypometabolic, supporting a hypothesis that ALS patients' daily oral intakes of calories fail to match their energy requirements, thus exacerbating their condition. This current study investigates and compares substrate utilization using a metabolic cart in controls and in ALS patients who are on and off ventilatory support to examine differences in substrate utilization between the two groups of ALS patients and the controls. (Substrate utilization is essentially the percentage of fats, carbohydrates, and protein utilized by the body.) The study will increase our understanding of the nutritional needs of ALS patients and improve our ability to provide the best possible nutrition in progressive illness.
Conditions
Sponsors & Collaborators
-
MDA/ALS Center of Hope
collaborator OTHER -
Drexel University College of Medicine
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- United States
Study Locations
More Related Trials
-
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
NCT02000713 ·Status: TERMINATED ·Phase: NA
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Brown Adipose Tissue in ALS
NCT03150290 ·Status: COMPLETED ·Phase: NA
-
Dietary Approach to Improving Quality of Life in Amyotrophic Lateral Sclerosis
NCT03659422 ·Status: WITHDRAWN ·Phase: NA
-
High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
NCT00983983 ·Status: COMPLETED ·Phase: PHASE2
-
Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
NCT00718003 ·Status: TERMINATED
-
Fatigue in Patients With Amyotrophic Lateral Sclerosis
NCT04468191 ·Status: WITHDRAWN ·Phase: NA
-
Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients
NCT02152449 ·Status: COMPLETED ·Phase: NA
-
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
NCT00718458 ·Status: COMPLETED
-
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
NCT06771414 ·Status: NOT_YET_RECRUITING
-
Validation of a New Device to Measure Neuromuscular Disease Progression
NCT00606918 ·Status: COMPLETED
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
Mitochondrial Functions and Oxidative Stress in ALS Patients
NCT00331812 ·Status: UNKNOWN
-
Exercise and Disease Progression in Amyotrophic Lateral Sclerosis Patients
NCT03326622 ·Status: COMPLETED ·Phase: NA
-
The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis
NCT00160004 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis
NCT02969759 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)
NCT01016522 ·Status: TERMINATED ·Phase: PHASE3
-
LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS
NCT07312240 ·Status: RECRUITING ·Phase: NA
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED
-
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT00337402 ·Status: COMPLETED
-
Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)
NCT02572479 ·Status: COMPLETED
-
Neuromuscular Magnetic Stimulation in ALS Patients
NCT03618966 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient
NCT00718016 ·Status: TERMINATED
-
Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation
NCT00116558 ·Status: COMPLETED ·Phase: NA